Xilio Therapeutics, Inc. (XLO) earnings
Quarterly results of Xilio Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Xilio Therapeutics, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Xilio Therapeutics, Inc. reported revenue of $18.7M (+131.2% on the same quarter a year earlier) and a net loss of $6.4M.
Diluted earnings per share were -$0.33.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $18.7M | +131.2% | -$6.4M | -$0.33 |
| Q1 FY2026 | $12.6M | +331.7% | -$9.5M | -$0.58 |
| Q4 FY2025 | $13.7M | - | $10.4M | - |
| Q3 FY2025 | $19.1M | +742.5% | -$16.3M | -$0.11 |
| Q2 FY2025 | $8.1M | - | -$15.8M | -$2.30 |
| Q1 FY2025 | $2.9M | - | -$13.3M | -$2.49 |
| Q4 FY2024 | - | - | -$13.1M | - |
| Q3 FY2024 | $2.3M | - | -$14M | -$0.22 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
When is Xilio Therapeutics, Inc.'s next earnings date?
Xilio Therapeutics, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Xilio Therapeutics, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Xilio Therapeutics, Inc. reported revenue of $18.7M and a net loss of $6.4M. The figures come from its filing with the SEC.
Is Xilio Therapeutics, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $18.7M, up 131.2% from $8.1M in the same quarter a year earlier.
Get an email when XLO reports
Follow XLO and we email you its next results the day they are filed, with the numbers explained.